Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Healthcare Biotechnology
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > This PR news was available on Friday.
View:
Post by Mannequin on Feb 20, 2024 7:54am

This PR news was available on Friday.

I read it but wondered if they would PR it today. They did.

https://twitter.com/FrontImmunol/status/1758609580672892960

Comment by Joemare on Feb 20, 2024 8:34am
cGAS-STING Pathway: can actually trigger interest in TH.....let's see.  From a review regarding this pathway: We note that there are major drug discovery efforts currently under way to identify and translate agonists of the cGAS–STING pathway as vaccine adjuvants or as anticancer immunostimulatory agents, and these topics have been extensively covered in recent reviews. By contrast, in ...more  
Comment by Trogarzon on Feb 20, 2024 8:40am
Maybe they can raise 100M @ 5$ soon to finish the work... woohoo...
Theratechnologies Inc